黄山胶囊收盘上涨1.51%，滚动市盈率42.00倍，总市值22.16亿元

Core Viewpoint - Huangshan Capsule's stock closed at 7.41 yuan, up 1.51%, with a rolling PE ratio of 42.00, marking a new low in 325 days, and a total market value of 2.216 billion yuan [1][2] Company Overview - Anhui Huangshan Capsule Co., Ltd. specializes in the research, production, and sales of gelatin hollow capsules and enteric-coated gelatin hollow capsules, being one of the earliest manufacturers in China with over 30 years of high-quality production history [1] - The company has a strong reputation in the pharmaceutical hollow capsule industry and is a member of the China Pharmaceutical Packaging Association, recognized for its contributions [1] Financial Performance - In Q1 2025, the company achieved an operating income of 119 million yuan, a year-on-year increase of 0.53%, and a net profit of 18.837 million yuan, up 22.90% year-on-year, with a gross profit margin of 29.26% [2] Market Position - Huangshan Capsule ranks 84th in the industry based on PE ratio, with the average PE ratio for the medical device industry at 50.64 and the median at 37.05 [2] - The average market value of the industry is 10.91 billion yuan, while Huangshan Capsule's market value is 2.216 billion yuan [2] Shareholder Information - As of March 31, 2025, Huangshan Capsule had 18,378 shareholders, a decrease of 26 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1]